Por: ABC7 World February 16, 2023
on May 11, which meant that federal funding for vaccines would soon dry up and uninsured Americans would have to pay out of pocket for their boosters.Among the critics of Moderna's reported consideration of a price increase -- from about $26 a shot to as much as $130 -- was Sen. Bernie Sanders, who has long advocated for government-funded health care and alleged the move would result in deaths.How many of these Americans will die from COVID... + full article
CNBC USA Health February 16, 2023
Moderna CEO, Stephane Bancel attends 2019 Forbes Healthcare Summit at the Jazz at Lincoln Center on December 05, 2019 in New York City.Steven Ferdman Getty Images CEO Stéphane Bancel will testify before the Senate health committee in March over the company's price for its... + más
Moderna prepares for transition year as COVID vaccine sales wane, CEO says. | The Boston Globe
Moderna CEO: 400% price hike on COVID vaccine “consistent with the value” | Ars Technica
ABC News USA Health February 16, 2023
Moderna will keep its COVID vaccine on the market at no cost to consumers, even after the federal government stops paying for it, the company announced Wednesday.Everyone in the United States will have access to Moderna's COVID-19 vaccine regardless of their ability to pay,... + más
Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes
Moderna CEO Stéphane Bancel will testify before Senate next month on Covid vaccine price hike | CNBC
MarketWatch USA Business January 18, 2023
(ticker: MRNA) said Tuesday its experimental messenger RNA-based RSV vaccine, known as mRNA-1345, was 83.7% effective at preventing less severe disease in adults aged 60 and above, and 82.4% effective at preventing more severe disease. The company only released topline results,... + más
GSK vaccine for older adults granted FDA priority review | Fox Business
Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history | CNBC
CNBC USA Health December 06, 2022
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
Forbes USA Business November 29, 2022
Getty Images Key Takeaways Moderna became a household name for creating one of the first COVID-19 vaccines, helping to loosen up pandemic restrictions globally. Moderna’s stock went up during the pandemic for apparent reasons as countries were scrambling to purchase mass... + más
The Advocate USA Crime October 10, 2022
vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
The Verge USA Health September 24, 2022
Moderna is suing Pfizer over its coronavirus vaccineModerna is suing Pfizer over its coronavirus vaccine / The company is filing patent infringement lawsuits against Pfizerp>span:first-child]:text-black text-blurple>By Aug 26, 2022, 12:37 PM UTC Share this story... + más
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
About iurex | Privacy Policy | Disclaimer |